The British Journal of Radiology, Vol 70, Issue 833 473-481, Copyright © 1997 by British Institute of Radiology

ARTICLES

A comparison between 111In-anti-E-selectin mAb and 99Tcm-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis

F Jamar, PT Chapman, DH Manicourt, DM Glass, DO Haskard and AM Peters
Department of Imaging (Nuclear Medicine Unit), Hammersmith Hospital and Royal Postgraduate Medical School, London, UK.

We have developed and validated a method for imaging inflammation using a monoclonal antibody (1.2B6) against E-selectin, an endothelial-cell specific adhesion molecule. This study was undertaken to compare 111In-1.2B6 with 99Tcm-labelled non-specific IgG (99Tcm-HIG) in the detection of synovitis in 11 patients with rheumatoid arthritis (RA). Imaging was performed 4 h and 20-24 h post-injection (pi) of 555 MBq 99Tcm-HIG and 15 MBq 111In-1.2B6. Scintigraphic results were compared with clinical scores of joint involvement. Joint uptake was semiquantitated. The scintigraphic appearances with both tracers correlated well, although 111In-1.2B6 at 24 h showed the highest detection rate. Taking joint tenderness or swelling as evidence of clinical activity, the sensitivity of 111In-1.2B6 at 4 h and 24 h was 69% and 82%, respectively, compared with 69% and 62% for 99Tcm-HIG. 111In-1.2B6 also displayed abnormal activity over a number of joints that appeared silent on clinical examination. Joint-to-soft tissue ratios were higher for 111In-1.2B6 at 24 h (4.0 +/- 1.9; p < 0.0001 vs all) than at 4 h (2.4 +/- 1.4) or than for 99Tcm-HIG at 4 h and 24 h (1.6 +/- 0.5 and 2.3 +/- 0.7, respectively). Net 111In counts over joints increased significantly between 4 h and 24 h (mean change: 54 +/- 40%). This study demonstrates that 111In-1.2B6 scintigraphy is a sensitive method by which to assess RA activity and that targeting is more intense and specific than using 99Tcm-HIG. However, the optimum time for 111In-1.2B6 scintigraphy is 24 h whereas good results are already obtained with 99Tc-HIG at 4 h pi. Current efforts are directed at developing 99Tcm-labelled 1.2B6 for imaging endothelial activation.

This article has been cited by other articles:

				G. Malviya, C. D'Alessandria, E. Bonanno, V. Vexler, R. Massari, C. Trotta, F. Scopinaro, R. Dierckx, and A. Signore Radiolabeled Humanized Anti-CD3 Monoclonal Antibody Visilizumab for Imaging Human T-Lymphocytes J. Nucl. Med., October 1, 2009; 50(10): 1683 - 1691. [Abstract] [Full Text] [PDF]

				T. Garrood, M. Blades, D. O. Haskard, S. Mather, and C. Pitzalis A novel model for the pre-clinical imaging of inflamed human synovial vasculature Rheumatology, August 1, 2009; 48(8): 926 - 931. [Abstract] [Full Text] [PDF]

				F P P Martins, B Gutfilen, S A L de Souza, M N L de Azevedo, L R Cardoso, R Fraga, and L M B da Fonseca Monitoring rheumatoid arthritis synovitis with 99mTc-anti-CD3 Br. J. Radiol., January 1, 2008; 81(961): 25 - 29. [Abstract] [Full Text] [PDF]

				P. R. Reynolds, D. J. Larkman, D. O. Haskard, J. V. Hajnal, N. L. Kennea, A. J. T. George, and A. D. Edwards Detection of Vascular Expression of E-selectin in Vivo with MR Imaging Radiology, November 1, 2006; 241(2): 469 - 476. [Abstract] [Full Text] [PDF]

				P Barrera, W J G Oyen, O C Boerman, and P L C M van Riel Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis Ann Rheum Dis, September 1, 2003; 62(9): 825 - 828. [Abstract] [Full Text] [PDF]

				F. Jamar, F. A. Houssiau, J.-P. Devogelaer, P. T. Chapman, D. O. Haskard, V. Beaujean, C. Beckers, D.-H. Manicourt, and A. M. Peters Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis Rheumatology, January 1, 2002; 41(1): 53 - 61. [Abstract] [Full Text] [PDF]

				S. M. Moghimi, A. C. Hunter, and J. C. Murray Long-Circulating and Target-Specific Nanoparticles: Theory to Practice Pharmacol. Rev., June 1, 2001; 53(2): 283 - 318. [Abstract] [Full Text] [PDF]

				A. M. Peters Nuclear medicine in vasculitis Rheumatology, May 1, 2000; 39(5): 463 - 470. [Full Text] [PDF]

				R. A. Watts, D. G. I. Scott, C. D. Pusey, and C. M. Lockwood Vasculitis--aims of therapy. An overview Rheumatology, March 1, 2000; 39(3): 229 - 232. [Full Text] [PDF]